Uterine Balloon Treatment for Heavy Period Bleeding.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-03-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to determine the proportion of women who achieve permanent cessation of bleeding after Uterine Balloon Therapy (UBT) for the treatment of heavy uterine bleeding.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CavatermTM vs TCRE in Women With DUB

NCT00549159

Dysfunctional Uterine Bleeding

UNKNOWN PHASE4

Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device

NCT02449304

Heavy Menstrual Bleeding

UNKNOWN PHASE4

Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study

NCT00768742

Leiomyoma Uterine Fibroids Menorrhagia

WITHDRAWN NA

Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

NCT00837161

Uterine Fibroids Uterine Leiomyomata

COMPLETED PHASE1/PHASE2

Immediate and Delayed Intrauterine Balloon in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

NCT03171454

Intrauterine Adhesion

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was also designed to determine the effect of a post procedure curettage on bleeding patterns and post-operative discharge and pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menorrhagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Uterine Balloon Therapy with post procedure curettage

Group Type EXPERIMENTAL

Uterine Balloon Therapy

Intervention Type DEVICE

UBT with post procedure curettage

2

Uterine Balloon Therapy without post-procedure curettage

Group Type EXPERIMENTAL

Uterine Balloon Therapy

Intervention Type DEVICE

UBT without post procedure curettage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Uterine Balloon Therapy

UBT with post procedure curettage

Intervention Type DEVICE

Uterine Balloon Therapy

UBT without post procedure curettage

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

with post procedure curettage without post procedure curettage

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female at least 30 years of age who is premenopausal and for whom childbearing is complete.
* Excessive menstrual bleeding documented by a diary score of at least 150.
* Have documented 3 months failed medical therapy or either a) contraindicated for or b) refused medical therapy.
* Have an anatomically normal uterine cavity sounding at least 4cm, but not greater than 12cm.
* Have a normal pap smear and no unexplained abnormal pap smears within 1 year of the procedure.
* Agree not to switch from hormonal to non-hormonal contraception or vice versa during or just prior to the study.
* Agree to use reliable contraception throughout the study.
* Freely agree to participate in the study, including all study related procedures and evaluations, and document this agreement by signing informed consent documentation.

Exclusion Criteria

* Active pelvic inflammatory disease (PID) or recurrent chronic PID.
* Active genital or urinary tract infection at the time of the procedure.
* History of malignancy of the reproductive system within 5 years of the procedure or have ever had malignancy of the endometrium.
* Endometrial neoplasia, determined by endometrial biopsy taken within 6 months of procedure.
* Cavity distorting submucous myoma(s) determined by preoperative hysterogram, hysteroscopy, or transvaginal sonography within 6 months of the procedure.
* Previous endometrial ablation procedure.
* Previous uterine surgeries (such as full thickness myomectomy, subserosal myomectomy, uterine reconstruction, or any surgery in which thinning of the uterine musculature could occur) except for low transverse caesarean section.
* Pregnant or desirous of future pregnancy.
* Taken endometrial suppression medication, except for oral contraceptives, within 3 months of the procedure.
* Concurrent open or laparoscopic surgery.

Minimum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No